American Heart Journal

1

Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: Findings from the National Heart, Lung and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE)

Jannet F. Lewis, Susan McGorray, Lang Lin, Carl J. Pepine, Bernard Chaitman, Mark Doyle, Daniel Edmundowicz, Barry L. Sharaf, C. Noel Bairey Merz

Journal:

Year:

2005

Language:

english

File:

PDF, 161 KB

english, 2005

2

Reducing the costs of phase III cardiovascular clinical trials

Eric L. Eisenstein, Philip W. Lemons II, Barbara E. Tardiff, Kevin A. Schulman, M. King Jolly, Robert M. Califf

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

3

Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes

Yan Zhang, Anna K.Y. Chan, Cheuk-Man Yu, Wynnie W.M. Lam, Gabriel W.K. Yip, Wing-Hong Fung, Nina M.C. So, Mei Wang, John E. Sanderson

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 478 KB

english, 2005

4

Patients with heart failure who die in hospice

Cheryl Hoyt Zambroski, Debra K. Moser, Lynn P. Roser, Seongkum Heo, Misook L. Chung

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 180 KB

english, 2005

5

Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction

Henning Steen, Stephanie Lehrke, Uwe K.H. Wiegand, Constanze Merten, Lydia Schuster, Gert Richardt, Christian Kulke, Hans B. Gehl, Joao A. Lima, Hugo A. Katus, Evangelos Giannitsis

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 160 KB

english, 2005

6

Electrocardiographic damage scores and cardiovascular mortality

Kelly Richardson, Gregory Engel, Takuya Yamazaki, Sung Chun, Victor F. Froelicher

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 316 KB

english, 2005

7

Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients

Stefan John, Markus P. Schneider, Christian Delles, Johannes Jacobi, Roland E. Schmieder

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 163 KB

english, 2005

8

Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial

Charles S. Smith, Christopher P. Cannon, Carolyn H. McCabe, Sabina A. Murphy, Jane Bentley, Eugene Braunwald

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 194 KB

english, 2005

9

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

Robert P. Frantz, Lyle J. Olson, Diane Grill, Soundos K. Moualla, Susan M. Nelson, Thomas P. Nobrega, Richard D. Hanna, Richard J. Backes, Farouk Mookadam, Denise Heublein, Kent R. Bailey, John C. Bur

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 260 KB

english, 2005

10

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study

Stella M. Macin, Eduardo R. Perna, Eduardo F. Farías, Valeria Franciosi, Jorge R. Cialzeta, Mónica Brizuela, Fernanda Medina, Carlos Tajer, Hernan Doval, Reynaldo Badaracco

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

11

Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting

Vivek Rajagopal, Hitinder S. Gurm, Richard C. Brunken, Claire E. Pothier, Deepak L. Bhatt, Michael S. Lauer

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 187 KB

english, 2005

12

Prevalence of anemia and effects on mortality in patients with heart failure

JoAnn Lindenfeld

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 175 KB

english, 2005

13

Coronary drug-eluting stent development: Issues in trial design

Neal I. Muni, Robert M. Califf, Jonette R. Foy, Ashley B. Boam, Bram D. Zuckerman, Richard E. Kuntz

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 328 KB

english, 2005

14

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy

Akiyoshi Ogimoto, Yuji Shigematsu, Jitsuo Higaki, Tetsuro Miki

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 44 KB

english, 2005

15

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Aldo P. Maggioni, Roberto Latini, Peter E. Carson, Steven N. Singh, Simona Barlera, Robert Glazer, Serge Masson, Elisabetta Cerè, Gianni Tognoni, Jay N. Cohn

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 306 KB

english, 2005

16

Statin therapy—Time to turn the focus from efficacy to implementation?

Michael Blazing

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

17

Statins in acute coronary syndromes: The sooner, the better?

Gregory G. Schwartz

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

18

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

T.-Christian H. Mix, Robert M. Brenner, Mark E. Cooper, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans-Henrik Parving, Brian J.G. Pereir

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 181 KB

english, 2005

19

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation

Charles R. Kerr, Karin H. Humphries, Mario Talajic, George J. Klein, Stuart J. Connolly, Martin Green, John Boone, Robert Sheldon, Paul Dorian, David Newman

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 266 KB

english, 2005

20

Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS)

Joachim H. Ix, Nestor Mercado, Michael G. Shlipak, Pedro A. Lemos, Eric Boersma, Wietze Lindeboom, William W. O'Neill, William Wijns, Patrick W. Serruys

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 347 KB

english, 2005

21

Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression

Giuseppe G.L. Biondi-Zoccai, Antonio Abbate, Pierfrancesco Agostoni, Luca Testa, Francesco Burzotta, Marzia Lotrionte, Carlo Trani, Luigi M. Biasucci

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 144 KB

english, 2005

22

Primary stenting of occluded native coronary arteries II—Rationale and design of the PRISON II study: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions

Braim M. Rahel, Gert J. Laarman, Maarten J. Suttorp

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 70 KB

english, 2005

23

Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound

Anna Sonia Petronio, Giovanni Amoroso, Ugo Limbruno, Barbara Papini, Marco De Carlo, Andrea Micheli, Nicola Ciabatti, Mario Mariani

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 157 KB

english, 2005

24

Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus

Shelby D. Reed, Kevin J. Anstrom, Ameet Bakhai, Andrew H. Briggs, Robert M. Califf, David J. Cohen, Michael F. Drummond, Henry A. Glick, Ari Gnanasakthy, Mark A. Hlatky, Bernie J. O'Brien, Frank M. To

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 225 KB

english, 2005

25

Plaque regression—A new target for antiatherosclerotic therapy

Juhana Karha, Deepak L. Bhatt

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

26

New-onset paroxysmal atrial fibrillation: Is permanence inevitable?

Kristen K. Patton, Richard L. Page

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

27

Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes

David E. Kandzari, Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack Jr., Robert A. Harrington, E. Magnus Ohman, W. Brian Gibler, Eric D. Peterson

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 119 KB

english, 2005

28

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Christie M. Ballantyne, Nicola Abate, Zhong Yuan, Thomas R. King, Joanne Palmisano

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 460 KB

english, 2005

29

Letter to the editor

Jeff Nagge, Olavo Fernandes, Jin Huh

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 41 KB

english, 2005

30

Reply

Michael W. Kruse, Jeremy J. Lee

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 47 KB

english, 2005

31

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Paul W. Armstrong, Peter X. Adams, Hussein R. Al-Khalidi, Christian Hamm, David Holmes, William O'Neill, Thomas G. Todaro, Alec Vahanian, Frans Van de Werf, Christopher B. Granger

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 179 KB

english, 2005

32

Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?

Moutasim H. Al-Shaer

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 35 KB

english, 2005

33

Editorial Board

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 32 KB

english, 2005

34

Information for Authors

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 93 KB

english, 2005

35

Information for Readers

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 42 KB

english, 2005

36

Change of address box

Journal:

American Heart Journal

Year:

2005

Language:

english

File:

PDF, 53 KB

english, 2005

37

Volume 149; Issue 3

Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: Findings from the National Heart, Lung and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE)

Reducing the costs of phase III cardiovascular clinical trials

Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes

Patients with heart failure who die in hospice

Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction

Electrocardiographic damage scores and cardiovascular mortality

Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients

Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study

Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting

Prevalence of anemia and effects on mortality in patients with heart failure

Coronary drug-eluting stent development: Issues in trial design

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Statin therapy—Time to turn the focus from efficacy to implementation?

Statins in acute coronary syndromes: The sooner, the better?

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation

Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS)

Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression

Primary stenting of occluded native coronary arteries II—Rationale and design of the PRISON II study: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions

Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound

Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus

Plaque regression—A new target for antiatherosclerotic therapy

New-onset paroxysmal atrial fibrillation: Is permanence inevitable?

Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Letter to the editor

Reply

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?

Editorial Board

Information for Authors

Information for Readers

Change of address box

TOC